Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

FDA approves Regeneron’s Eylea for the treatment of retinopathy of prematurity in infants

February 9, 2023 Research and Development

The FDA has approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of retinopathy of prematurity (ROP) in preterm infants. …
News

Johnson & Johnson’s Ethicon undertakes first robot-assisted kidney stone removal

February 8, 2023 Research and Development

Johnson & Johnson (J&J) medtech company, Ethicon, has announced its first robotic-assisted kidney stone removal using its Monarch platform. The …
News

Sandoz files Amgen biosimilar drug for osteoporosis

February 8, 2023 Research and Development

Switzerland-based Sandoz has filed a proposed biosimilar of Amgen’s osteoporosis drug Prolia/Xgeva with the FDA. According to Sandoz, over 10 …
News

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023 Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …
News

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023 Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …
News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023 Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …
News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023 Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …
News

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023 Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …
News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023 Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …
News

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023 Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …
News

First Wave BioPharma announces phase 2 trial

January 31, 2023 Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …
News

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023 Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …
News

IsoChemiX develop molecules to speed up R&D process

January 27, 2023 Research and Development

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …
News

AI finds liver cancer drug candidate in only 30 days

January 26, 2023 Research and Development

With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …
News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023 Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026